Proteasome Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

  • Single User License $3500

Proteasome Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

Status : October, 2020 | Medical Devices | PPT format

Report Digest


Global Proteasome Inhibitors Market: Overview

Proteasome refers to a process of degradation of protein degradation within the cell that can assimilate various protein into short polypeptides and amino acids. Proteasome are comprised of protein and they need Adenosine Triphosphate (ATP) to function. Proteasome come with the opening at both sides of the ends so that the protein is attached for the purpose of degradation. Nearly 30,000 proteasomes exist in a human cell.

The absorption of proteins eliminates extra enzymes and provides amino acids for synthesis of new protein. Proteasome inhibitors obstruct the movement of cellular complex and proteasome, which break down the proteins. Protein inhibitors influence the breaking down of pro-apoptotic factors like p53 protein. Proteasome inhibitors finds its application in the development of research tools and treatment of cancers.

The global proteasome inhibitors market has been segmented on the basis of the following parameters: drugs, medical condition, end user, and region.

Global Proteasome Inhibitors Market: Notable Developments

Some of the leading developments pertaining to the global proteasome Inhibitors market are mentioned below:

  • In 2018, Tokyo-based Takeda Pharmaceutical Co. completed the acquisition of Ireland-based drugmaker Shire PLC. Following the acquisition, Shire PLC became a wholly owned subsidiary. Takeda Pharmaceutical Co. is famed for its expertise in neuroscience, oncology, and gastroenterology, and its objective is to increase sales of medicines for rare illness such as hemophilia. Shire PLC is an expert in the treatment for such rare diseases. Takeda Pharmaceutical Co also aims to expand its business in the U.S. market through the deal.
  • In 2019, Johnson & Johnson acquired U.S.-based Auris Health, Inc. Johnson and Johnson will take advantage of the latter’s technology of robotic platform, which is presently utilized in therapeutic and diagnostic procedures of the lung. Johnson & Johnson will, hence, further its commitment of battling lung cancer and improve its portfolio of digital surgery across multiple surgical specialties.

Some of the most prominent competitors operating in the competitive landscape of global proteasome inhibitors market include –

  • Takeda Pharmaceutical Company Limited
  • TG Therapeutics Inc.
  • Millennium Pharmaceuticals Inc
  • Johnson & Johnson’s
  • MimiVAx LLC

The proteasome inhibitors market is concentrated to some extent with handful of players dominating the shares of global proteasome inhibitors market. The market is experiencing a growing collaboration between market vendors, which will substantially diminish the market competition amongst vendors.

Global Proteasome Inhibitors Market: Growth Drivers

Prevalence of Various Types of Cancer Triggers Market Growth

The global proteasome inhibitors market is likely to be driven by the rise in prevalence of various types of cancers across the globe. The market for myeloma drugs is the target of global proteasome inhibitors market as the cancer cells have higher number of proteasome activity.

Furthermore, industry and research institutes driving the growth of the market carry out the research on proteasome inhibitors. Research tools explore various segments of health issues such as multiple myeloma and hence triggers growth of the global proteasome inhibitors market. A case in point is launch of Ninlaro to the market by Takeda Pharmaceutical Company Limited in 2015.

Proteasome inhibitors are often regarded as safe. However, the treatment utilizing these drugs could result in severe side-effects in a few patients. For example, treatment with Carfilzomib might cause harmful effects such as liver failure, lung damage, blood clots, pulmonary hypertension, and tumor lysis syndrome. Such side-effects can restrain the growth of global proteasome inhibitors market during forecast timeframe.

Global Proteasome Inhibitors Market: Regional Outlook

The North America proteasome inhibitors market held around 47% of the total market revenue in 2018 due to the rising incidences of various types of cancer indications such as non-Hodgkin’s lymphoma and multiple myeloma.

The global proteasome inhibitors market is segmented based on:

Drug

  • Bortezomib
  • Carfilzomib
  • Ixazomib

Medical Condition

  • Lymphoma
  • Mantle Cell Lymphoma
  • Multiple Myeloma

End User

  • Hospital
  • Clinics
  • Oncology Centers

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?